Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer

[1]  H. Hollema,et al.  Ovarian cancer in Lynch syndrome; a systematic review. , 2016, European journal of cancer.

[2]  P. Møller,et al.  Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database , 2015, Gut.

[3]  D. Evans,et al.  Cancer risk in Lynch Syndrome , 2013, Familial Cancer.

[4]  Laetitia Huiart,et al.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. , 2011, JAMA.

[5]  A. Auranen,et al.  A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families , 2011, Acta obstetricia et gynecologica Scandinavica.

[6]  A. de la Chapelle,et al.  The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means? , 2011, Cancer Prevention Research.

[7]  P. Møller,et al.  Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds , 2009, Journal of Medical Genetics.

[8]  H. Hollema,et al.  Management of extracolonic tumours in patients with Lynch syndrome. , 2009, The Lancet. Oncology.

[9]  D. Evans,et al.  Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations , 2009, Clinical genetics.

[10]  J. Mecklin,et al.  The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome , 2008, International journal of cancer.

[11]  P. Møller,et al.  Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers , 2008, Journal of Medical Genetics.

[12]  A. Spurdle,et al.  Molecular, Pathologic, and Clinical Features of Early-Onset Endometrial Cancer: Identifying Presumptive Lynch Syndrome Patients , 2008, Clinical Cancer Research.

[13]  G. Petersen,et al.  Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. , 2006, JAMA.

[14]  Å. Borg,et al.  The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. , 2006, Gynecologic oncology.

[15]  R. Ozols.  Ovarian Cancer: American Cancer Society Atlas of Clinical Oncology , 2003 .

[16]  J. Mecklin,et al.  The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. , 2001, Gynecologic oncology.

[17]  J. Berek,et al.  Ovarian cancer: epidemiology, biology, and prognostic factors. , 2000, Seminars in surgical oncology.

[18]  C. Lasset.  [Ovarian cancer epidemiology]. , 1995, Soins; la revue de reference infirmiere.

[19]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[20]  H. Lynch,et al.  Hereditary Ovarian Cancer: A Clinicopathological Study , 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[21]  M. Shaw,et al.  Hereditary factors in cancer. Study of two large midwestern kindreds. , 1966, Archives of internal medicine.

[22]  C. Bonaïti‐pellié,et al.  Cancer risks associated with germline mutations in MLH1, MSH2 and MSH6 genes in Lynch syndrome: results from the large nationwide French ERISCAM study , 2011 .

[23]  R. Broaddus,et al.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. , 2009, Cancer control : journal of the Moffitt Cancer Center.

[24]  K. Lu,et al.  Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis , 2007, Familial Cancer.

[25]  R. Coleman.  Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome , 2007 .

[26]  A. Chapelle.  The Incidence of Lynch Syndrome , 2004, Familial Cancer.